Reverse vaccinology: Basics and applications

Journal of Vaccines and Vaccination

Volumn 4, Issue 6, 2013, Pages

  Kanampalliwar, Amol M ^a   Soni, Rajkumar ^a   Girdhar, Amandeep ^a   Tiwari, Archana ^a  

^a UNIVERSITY INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Conventional vaccinology; Epitope prediction; Reverse vaccinology

Indexed keywords

EID: 84884803051     PISSN: None     EISSN: 21577560     Source Type: Journal    
DOI: 10.4172/2157-7560.1000194     Document Type: Article

References (47)

1. Sanou MP, De Groot AS, Murphey-Corb M, Levy JA, Yamamoto JK (2012) HIV-1 Vaccine Trials: Evolving Concepts and Designs. Open AIDS J 6: 274-288.
2. http://www.cdc.gov/
3. Lara HH, Garza-Treviño EN, Ixtepan-Turrent L, Singh DK (2011) Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds. J Nanobiotechnology 9: 30.
4. LM L: New strategies for vaccine development, SPCV 2010 2: e4
5. Ananya Manda, Vaccines History.
6. Sollner J, Grohmann R, Rapberger R, Perco P, Lukas A, et al. (2008) Analysis and prediction of protective continuous B-cell epitopes on pathogen proteins. Immunome Res 4: 1.
7. A vaccine produced by genetic engineering? Why not!
8. Buasri W, Impoolsup A, Boonchird C, Luengchaichawange A, Prompiboon P, et al. (2012) Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange. BMC Microbiol 12: 61.
9. Rinaudo CD, Telford JL, Rappuoli R, Seib KL (2009) Vaccinology in the genome era. J Clin Invest 119: 2515-2525.
10. Rappuoli R (2000) Reverse vaccinology. Curr Opin Microbiol 3: 445-450.
11. Flower DR, Macdonald IK, Ramakrishnan K, Davies MN, Doytchinova IA (2010) Computer aided selection of candidate vaccine antigens. Immunome Res 6 Suppl 2: S1.
12. Lefébure T, Stanhope MJ (2007) Evolution of the core and pan-genome of Streptococcus: positive selection, recombination, and genome composition. Genome Biol 8: R71.
13. Zhao Y, Wu J, Yang J, Sun S, Xiao J, et al. (2012) PGAP: pan-genomes analysis pipeline. Bioinformatics 28: 416-418.
14. Ansari HR, Raghava GP (2010) Identification of conformational B-cell Epitopes in an antigen from its primary sequence. Immunome Res 6: 6.
15. Agadjanyan MG, Ghochikyan A, Petrushina I, Vasilevko V, Movsesyan N, et al. (2005) Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide. J Immunol 174: 1580-1586.
16. Udhayakumar V, Anyona D, Kariuki S, Shi YP, Bloland PB, et al. (1995) Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1. J Immunol 154: 6022-6030.
17. Carruth LM, Greten TF, Murray CE, Castro MG, Crone SN, et al. (1999) An algorithm for evaluating human cytotoxic T lymphocyte responses to candidate AIDS vaccines. AIDS Res Hum Retroviruses 15: 1021-1034.
18. Shapiro SZ (2013) HIV Vaccine Development: Strategies for Preclinical and Clinical Investigation. AIDS Res Hum Retroviruses.
19. Yasutomi Y, Palker TJ, Gardner MB, Haynes BF, Letvin NL (1993) Synthetic peptide in mineral oil adjuvant elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes in rhesus monkeys. J Immunol 151: 5096-5105.
20. Azizi A, Ghorbani M, Soare C, Mojibian M, Diaz-Mitoma F (2007) Synergistic effect of combined HIV/HCV immunogens: a combined HIV-1/HCV candidate vaccine induces a higher level of CD8+ T cell-immune responses in HLA-A2.1 mice. Curr HIV Res 5: 211-219.
21. Cristillo AD, Wang S, Caskey MS, Unangst T, Hocker L, et al. (2006) Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine. Virology 346: 151-168.
22. De Groot AS (2006) Immunomics: discovering new targets for vaccines and therapeutics. Drug Discov Today 11: 203-209.
23. De Groot AS, Berzofsky JA (2004) From genome to vaccine--new immunoinformatics tools for vaccine design. Methods 34: 425-428.
24. Sirskyj D, Diaz-Mitoma F, Golshani A, Kumar A, Azizi A (2011) Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses. Immunol Cell Biol 89: 81-89.
25. www epivax.com/platform
26. Davies MN, Flower DR (2007) Harnessing bioinformatics to discover new vaccines. Drug Discov Today 12: 389-395.
27. El-Manzalawy Y, Honavar V (2010) Recent advances in B-cell epitope prediction methods. Immunome Res 6 Suppl 2: S2.
28. Flower DR (2007) Immunoinformatics and the in silico prediction of immunogenicity. An introduction. Methods Mol Biol 409: 1-15.
29. Odorico M, Pellequer JL (2003) BEPITOPE: predicting the location of continuous epitopes and patterns in proteins. J Mol Recognit 16: 20-22.
30. Alix AJ (1999) Predictive estimation of protein linear epitopes by using the program PEOPLE. Vaccine 18: 311-314.
31. Saha S, Raghava GP (2006) Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins 65: 40-48.
32. Schreiber A, Humbert M, Benz A, Dietrich U (2005) 3D-Epitope-Explorer (3DEX): localization of conformational epitopes within three-dimensional structures of proteins. J Comput Chem 26: 879-887.
33. Kulkarni-Kale U, Bhosle S, Kolaskar AS (2005) CEP: a conformational epitope prediction server. Nucleic Acids Res 33: W168-171.
34. Kolaskar AS, Kulkarni-Kale U (1999) Prediction of three-dimensional structure and mapping of conformational epitopes of envelope glycoprotein of Japanese encephalitis virus. Virology 261: 31-42.
35. Kim Y, Ponomarenko J, Zhu Z, Tamang D, Wang P, et al. (2012) Immune epitope database analysis resource. Nucleic Acids Res 40: W525-530.
36. Kaboré NF, Poda GE, Barro M, Cessouma R, Héma A, et al. (2012) [Impact of vaccination on admissions for Haemophilus influenzae b meningitis from 2004 to 2008 in Bobo Dioulasso, Burkina Faso]. Med Sante Trop 22: 425-429.
37. Ginsberg L (2004) Difficult and recurrent meningitis. J Neurol Neurosurg Psychiatry 75 Suppl 1: i16-21.
38. Anderson Santos, Amjad Ali, Eudes Barbosa, Artur Silva, Anderson Miyoshi, et al. (2011) The Reverse Vaccinology-A Contextual Overview. IIOABJ 2: 8-15.
39. Ramaswamy V, Cresence VM, Rejitha JS, Lekshmi MU, Dharsana KS, et al. (2007) Listeria--review of epidemiology and pathogenesis. J Microbiol Immunol Infect 40: 4-13.
40. Dilip Gore, Manish Pachkawade (2012) In silico Reverse Vaccinology Approach for Vaccine Lead Search in Listeria monocytogenes. BIOCOMPX 1:15-22.
41. Nayyar GM, Breman JG, Newton PN, Herrington J (2012) Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet Infect Dis 12: 488-496.
42. Geels MJ, Imoukhuede EB, Imbault N, van Schooten H, McWade T, et al. (2011) European Vaccine Initiative: lessons from developing malaria vaccines. Expert Rev Vaccines 10: 1697-1708.
43. Cole JN, Henningham A, Gillen CM, Ramachandran V, Walker MJ (2008) Human pathogenic streptococcal proteomics and vaccine development. Proteomics Clin Appl 2: 387-410.
44. Cherkasskiy BL (1999) A national register of historic and contemporary anthrax foci. J Appl Microbiol 87: 192-195.
45. Cohn DV (1996) Life and Times of Louis Pasteur. School of Dentistry, University of Louisville.
46. Mikesell P, Ivins BE, Ristroph JD, Vodkin MH, Dreier TM, et al. (1983) Plasmids, Pasteur, and Anthrax. ASM News 49: 320-322.
47. Pallavi Kashikar, Chandan Dipke (2012) Insilico Design and Development of Vaccine by Reverse Vaccinology Approach for Anthrax. Journal of Advanced Bioinformatics Applications and Research 3: 262-266.